Key result
Elevated HbA1c is strongly associated with metabolic syndrome, dyslipidemia, and atherosclerotic cardiovascular disease.
Why the study?
While HbA1c is a well-known indicator for diabetes control, its relationship with atherosclerotic events and serum lipid abnormalities in patients with metabolic syndrome warranted examination.
Is increasing HbA1c level associated with metabolic syndrome, dyslipidemia, and atherosclerotic cardiovascular events in patients with diabetes mellitus?
Cross-Sectional (n=226)
No
Is increasing HbA1c level associated with metabolic syndrome, dyslipidemia, and atherosclerotic cardiovascular events in patients with diabetes mellitus?
Answers are grounded in this paper and cite their sources.
In diabetic patients, elevated HbA1c correlates strongly with metabolic syndrome components, dyslipidemia, and atherosclerotic cardiovascular disease, supporting routine lipid and cardiovascular risk profiling in patients with poor glycemic control.
Introduction: HbA1c is well known indicator for control of DM.We try in this study to discuss the relationship between HbA1c level and some atherosclerotic events and S. lipid abnormalities in patients with metabolic syndrome.Patients and methods: 226pts involved in this study.Metabolic syndrome was assessed according to the US National Cholesterol Education Program Adult Treatment Panel III (2001) that was modified at 2004 , cross-sectional study performed in diabetes and endocrine center between 2008-2011.Parameters like Sex, races, age, job, residency, smoking had been taken into consideration , HbA1c was measured by immunoturbidimetric assay with a Cobra Integra 800 automatic analyzer (Roche Diagnostics, Basel, Switzerland) with a reference value of 4.4-6.0%.Conclusion: close relationship was found between HbA1c and hypertension, s.cholestrol, s. triglyceride, HDL, s.VLDL, and LDL and Increasing level of HbA1c was associated with increasing level of s. lipids, cardiovascular risk factors and severity of metabolic syndrome.
No takes yet. Share an insight, caveat, or question.
A 2019 study conducted a cross-sectional in Diabetes mellitus and metabolic syndrome (n=226). Elevated HbA1c levels (<7%, 7-7.9%, >8%) vs. Lower HbA1c levels (<7%) and absence of metabolic syndrome was evaluated on Association between HbA1c levels and metabolic syndrome, serum lipid abnormalities, and history of atherosclerotic cardiovascular events (p=0.000). Elevated HbA1c levels were associated with the presence of metabolic syndrome, dyslipidemia, and atherosclerotic disease.
Synapse has enriched 10 related papers. Consider them for comparative context: